144: Filer Information

Filer CIK

0001209726

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Amneal Pharmaceuticals, Inc.

SEC File Number

001-38485

Address of Issuer

400 CROSSING BLVD
BRIDGEWATER
NEW JERSEY
08807

Phone

(908) 947-3120

Name of Person for Whose Account the Securities are To Be Sold

BUCHI J KEVIN

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Director

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Charles Schwab Corp
3000 Schwab Way
Westlake � TX � 76262

168573

2917998.00

319353919

08/11/2026

Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

05/15/2017

Restricted Stock Award

Issuer

8020

05/15/2017

Equity Compensation

Common

05/03/2018

Restricted Stock Award

Issuer

3281

05/03/2018

Equity Compensation

Common

05/08/2019

Restricted Stock Award

Issuer

6107

05/08/2019

Equity Compensation

Common

05/05/2021

Restricted Stock Award

Issuer

46218

05/05/2021

Equity Compensation

Common

05/10/2024

Restricted Stock Award

Issuer

76453

05/10/2024

Equity Compensation

Common

05/05/2025

Restricted Stock Award

Issuer

40258

05/05/2025

Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Account Title: Memorandum of Trust of J. Kevin Buchi U/A DTD 11/04/2021 J. Kevin Buchi as trustee

Date of Notice

08/11/2026

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

J. Kevin Buchi

144: Filer Information

Submission Contact Information

144: Issuer Information

144: Securities Information

144: Securities To Be Sold

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)